These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31722125)

  • 1. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience.
    Sung S; Del Portillo A; Gonda TA; Kluger MD; Tiscornia-Wasserman PG
    Cancer Cytopathol; 2020 Jan; 128(1):29-35. PubMed ID: 31722125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic Categorization with Risk Stratification of Endoscopic Ultrasound-Guided Fine Needle Aspiration from Pancreatic Lesions Based on Guidelines of the Papanicolaou Society of Cytopathology: 12-Year Tertiary Care Experience.
    Nishith N; Rao RN; Rai P
    Discoveries (Craiova); 2021; 9(3):e134. PubMed ID: 34816002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience.
    Gonzalez-Mancera MS; Ahmadian SS; Gomez-Fernandez C; Velez-Torres J; Jorda M; García-Buitrago MT
    Diagn Cytopathol; 2022 Feb; 50(2):49-56. PubMed ID: 34856075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of malignancy and overall survival associated with the diagnostic categories in the World Health Organization Reporting System for Pancreaticobiliary Cytopathology.
    Hsiao WY; Wang Q
    Cancer Cytopathol; 2024 Oct; 132(10):635-645. PubMed ID: 38944695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of malignancy associated with diagnostic categories of the proposed World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Hoda RS; Arpin RN; Rosenbaum MW; Pitman MB
    Cancer Cytopathol; 2022 Mar; 130(3):195-201. PubMed ID: 34623767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology.
    Hoda RS; Finer EB; Arpin RN; Rosenbaum M; Pitman MB
    J Am Soc Cytopathol; 2019; 8(3):120-127. PubMed ID: 31097287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The WHO system versus the Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology for risk stratification-which is better?
    Kundu R; Kollabathula A; Gupta N; Rohilla M; Rana SS; Nada R; Kalra N; Basher RK; Gupta P; Dey P; Gupta R; Dutta U; Srinivasan R
    Diagn Cytopathol; 2024 Mar; 52(3):145-155. PubMed ID: 38059418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System.
    Nikas IP; Proctor T; Seide S; Chatziioannou SS; Reynolds JP; Ntourakis D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy risk associated with diagnostic categories defined by the Papanicolaou Society of Cytopathology pancreaticobiliary guidelines.
    Layfield LJ; Dodd L; Factor R; Schmidt RL
    Cancer Cytopathol; 2014 Jun; 122(6):420-7. PubMed ID: 24339321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Malignancy Using the Diagnostic Categories Proposed by the World Health Organization International System for Reporting Pancreaticobiliary Cytopathology.
    Gocun PU; Simsek B; Ekinci O; Ekmen N; Arhan M; Karakan T; Ibis M; Cindoruk M
    Acta Cytol; 2022; 66(6):475-485. PubMed ID: 35732161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benefits of the Papanicolaou Society of Cytopathology System for reporting pancreatobiliary cytology: A 2-year review from a single academic institution.
    Ozretić L; Simonović AV; Rathbone ML; Young MPA; Perez-Machado MA
    Cytopathology; 2021 Mar; 32(2):227-232. PubMed ID: 33415845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of endoscopic ultrasound guided fine needle aspiration cytology of pancreatic space occupying lesions by Papanicolaou Society of Cytopathology System: A five year study.
    Chaudhary D; Banga P; Sakhuja P; Goyal S; Saran RK; Batra VV; Srivastava S; Agarwal AK
    Diagn Cytopathol; 2023 Feb; 51(2):105-116. PubMed ID: 36165589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound-guided fine-needle aspiration of the pancreas.
    Lui SK; Hargett I; Pharaa Z; Aviles M; Botelho S; Feliciano DL; Kim V; Sigel K; Armstrong M; Wilson CE; Shah P; Soares K; Sigel C
    Cancer Cytopathol; 2023 Dec; 131(12):762-771. PubMed ID: 37602886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.
    Maleki Z; Baloch Z; Lu R; Shafique K; Song SJ; Viswanathan K; Rao RA; Lefler H; Fatima A; Wiles A; Jo VY; Wang H; Fadda G; Powers CN; Ali SZ; Pantanowitz L; Siddiqui MT; Nayar R; Klijanienko J; Barkan GA; Krane JF; Rossi ED; Callegari F; Kholová I; Bongiovanni M; Faquin WC; Pusztaszeri MP
    Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical cells in fine needle aspiration biopsies of pancreas: Causes, work-up, and recommendations for management.
    HooKim K; Reid MD
    Diagn Cytopathol; 2022 Apr; 50(4):196-207. PubMed ID: 34378874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience.
    Viswanathan K; Sung S; Scognamiglio T; Yang GCH; Siddiqui MT; Rao RA
    Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the new proposed Papanicolaou Society of Cytopathology terminology for pancreaticobiliary cytology in endoscopic US-FNA: A single-institutional experience.
    Saieg MA; Munson V; Colletti S; Nassar A
    Cancer Cytopathol; 2015 Aug; 123(8):488-94. PubMed ID: 25994860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.
    Faquin WC; Wong LQ; Afrogheh AH; Ali SZ; Bishop JA; Bongiovanni M; Pusztaszeri MP; VandenBussche CJ; Gourmaud J; Vaickus LJ; Baloch ZW
    Cancer Cytopathol; 2016 Mar; 124(3):181-7. PubMed ID: 26457584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The applicability of Papanicolaou Society of Cytopathology system on reporting endoscopic ultrasound-guided fine needle aspiration cytology specimens of pancreatic lesions in situations with limited availability of ancillary tests. Experience at a single laboratory.
    Mallik MK; Qadan LR; Al Naseer A; AlAli A; Al Ansari T; Naquib SAI; Das DK; Kapila K
    Cytopathology; 2020 Nov; 31(6):564-571. PubMed ID: 32535975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.